从康美药业虚假陈述案看我国独立董事制度改进与重构 The Improvement and Reconstruction of China’s Independent Director System from the Case of Kangmei Pharmaceutical’s False Statement
席敏智
争议解决Vol.9 No.6, 全文下载: PDF HTML XML DOI:10.12677/DS.2023.96452, November 22 2023
研发投入、独立董事与企业价值R&D Investment, Independent Directors and Corporate Value
汪先雯
运筹与模糊学Vol.14 No.3, 全文下载: PDF XML DOI:10.12677/orf.2024.143293, June 26 2024
我国独立董事违反勤勉义务的认定标准问题探究An Exploration of the Criteria for Determining the Violation of the Duty of Diligence by Independent Directors in China
房 燕 科研立项经费支持
法学Vol.12 No.3, 全文下载: PDF HTML XML DOI:10.12677/ojls.2024.123265, March 29 2024
保险公司董事会独立性与财务绩效的实证分析—基于美国保险市场的研究An Empirical Analysis about Board Independence and Financial Performance of Insurance Companies —Based on American Insurance Market
寇业富, 赵建川 国家科技经费支持
管理科学与工程Vol.6 No.1, 全文下载: PDF HTML XML DOI:10.12677/MSE.2017.61004, March 23 2017
上市公司治理中董事监督义务构造研究Research on the Construction of Supervisory Obligations of Directors in the Governance of Listed Companies
马 赛
法学Vol.11 No.6, 全文下载: PDF HTML XML DOI:10.12677/OJLS.2023.116702, November 7 2023
独立董事制度发展与优化——从康美药业案出发Development and Optimization of the Independent Director System—Starting from the Kangmei Pharmaceutical Case
蒋哲诚
法学Vol.11 No.6, 全文下载: PDF HTML XML DOI:10.12677/OJLS.2023.116891, November 24 2023